These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8882747)

  • 1. In vivo pharmacokinetic study for the assessment of poly(L-aspartic acid) as a drug carrier for colon-specific drug delivery.
    Leopold CS; Friend DR
    J Pharmacokinet Biopharm; 1995 Aug; 23(4):397-406. PubMed ID: 8882747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: steady-state pharmacokinetics in the rat.
    McLeod AD; Tolentino L; Tozer TN
    Biopharm Drug Dispos; 1994 Mar; 15(2):151-61. PubMed ID: 7516722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady-state pharmacokinetics of corticosteroid delivery from glucuronide prodrugs in normal and colitic rats.
    Nolen HW; Fedorak RN; Friend DR
    Biopharm Drug Dispos; 1997 Nov; 18(8):681-95. PubMed ID: 9373725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on the enzyme dependant colon targeting prodrug--dexamethasone succinate dextran and its tablets].
    Pang YN; Zhang ZR; Pang QJ; Li TL
    Yao Xue Xue Bao; 2001 Aug; 36(8):625-30. PubMed ID: 12579944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of site-specific delivery of dexamethasone-dextran prodrug in rat gastrointestinal tract].
    Zhou SY; Mei QB; Zhou J; Liu L; Li C; Zhao DH
    Yao Xue Xue Bao; 2001 May; 36(5):325-8. PubMed ID: 12584851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of glucocorticoid conjugate in rat gastrointestinal tract and its treatment for ulcerative colitis.
    Zhou SY; Mei QB; Liu L; Guo X; Qiu BS; Zhao DH; Cho CH
    Acta Pharmacol Sin; 2001 Aug; 22(8):761-4. PubMed ID: 11749853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colon-specific delivery of dexamethasone from a glucoside prodrug in the guinea pig.
    Tozer TN; Rigod J; McLeod AD; Gungon R; Hoag MK; Friend DR
    Pharm Res; 1991 Apr; 8(4):445-54. PubMed ID: 1871038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of an enzyme-dependent prodrug and evaluation of its potential for colon targeting.
    Pang YN; Zhang Y; Zhang ZR
    World J Gastroenterol; 2002 Oct; 8(5):913-7. PubMed ID: 12378641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colon-specific drug delivery based on a cyclodextrin prodrug: release behavior of biphenylylacetic acid from its cyclodextrin conjugates in rat intestinal tracts after oral administration.
    Minami K; Hirayama F; Uekama K
    J Pharm Sci; 1998 Jun; 87(6):715-20. PubMed ID: 9607948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colonic delivery of dexamethasone: a pharmacoscintigraphic evaluation.
    Kenyon CJ; Nardi RV; Wong D; Hooper G; Wilding IR; Friend DR
    Aliment Pharmacol Ther; 1997 Feb; 11(1):205-13. PubMed ID: 9042995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone 21-sulfate improves the therapeutic properties of dexamethasone against experimental rat colitis by specifically delivering the steroid to the large intestine.
    Kim I; Kong H; Lee Y; Hong S; Han J; Jung S; Jung Y; Kim YM
    Pharm Res; 2009 Feb; 26(2):415-21. PubMed ID: 18958401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celecoxib coupled to dextran via a glutamic acid linker yields a polymeric prodrug suitable for colonic delivery.
    Lee Y; Kim J; Kim W; Nam J; Jeong S; Lee S; Yoo JW; Kim MS; Jung Y
    Drug Des Devel Ther; 2015; 9():4105-13. PubMed ID: 26251576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budesonide-beta-D-glucuronide: a potential prodrug for treatment of ulcerative colitis.
    Nolen H; Fedorak RN; Friend DR
    J Pharm Sci; 1995 Jun; 84(6):677-81. PubMed ID: 7562403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colonic delivery of dexamethasone from a prodrug accelerates healing of colitis in rats without adrenal suppression.
    Fedorak RN; Haeberlin B; Empey LR; Cui N; Nolen H; Jewell LD; Friend DR
    Gastroenterology; 1995 Jun; 108(6):1688-99. PubMed ID: 7768373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colon-specific delivery of prednisolone-appended alpha-cyclodextrin conjugate: alleviation of systemic side effect after oral administration.
    Yano H; Hirayama F; Kamada M; Arima H; Uekama K
    J Control Release; 2002 Feb; 79(1-3):103-12. PubMed ID: 11853922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
    Nakase H; Okazaki K; Tabata Y; Chiba T
    J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical approaches to colon targeted drug delivery systems.
    Chourasia MK; Jain SK
    J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents.
    McLeod AD; Friend DR; Tozer TN
    J Pharm Sci; 1994 Sep; 83(9):1284-8. PubMed ID: 7530303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colon-specific delivery of celecoxib is a potential strategy to improve toxicological and pharmacological properties of the selective Cox-2 inhibitor: implication in treatment of familiar adenomatous polyposis.
    Lee Y; Kim H; Kim W; Yoon JH; Jeong SH; Jung Y
    J Drug Target; 2012 Jul; 20(6):524-34. PubMed ID: 22632102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A glucocorticoid prodrug facilitates normal mucosal function in rat colitis without adrenal suppression.
    McLeod AD; Fedorak RN; Friend DR; Tozer TN; Cui N
    Gastroenterology; 1994 Feb; 106(2):405-13. PubMed ID: 7507873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.